Chris Ball’s Post

Fascinating webinar on how three key new modalities will impact oncology care and what that means for industry.

Take a deep dive into the evolving #oncology innovation area. Expect insights into how to navigate this fast-paced environment and how to achieve oncology launch excellence, and learn from real life case studies. Register today: https://bit.ly/3Zh56x7

As #ESMO2024 draws to a close, it's clear that even as #oncology enters the second half of the second decade of being the world's most valuable therapy area, the innovative pipeline for cancer therapies remains exceptionally strong, with exciting new MoAs emerging in bispecifics, anti-body-drug conjugates, and radioligands. However, pipeline promise needs to translate to commercial reality for success. Find out more in our exciting webinar on September 26th, where we'll be talking the oncology pipe and oncology #LaunchExcellence - register now!

It's almost #ASCO24 and we'll be there to learn and explore. Did you know that last year, we collaborated on 148 oncology assets, 91 of which were small molecule? In the last two years, we've collaborated with the top 20 oncology products globally. We're excited to help get the right treatments to the right patients, faster. If you're keen to understand more how we do this, please visit our booth! #oncology #biopharma #biotech #reimaginehealth #connectedcapabilities #inizio Inizio Advisory Inizio Medical Inizio Evoke Inizio Engage

Delays in #oncology research can have dire consequences – participant lives could be at stake.  Therefore, early phase oncology sponsors need to keep their study timelines on track, and a fully integrated CDMS/EDC solution could be the key. Read our latest blog to learn how a CDMS/EDC system that integrates with eConsent, eCOA/ePRO, and RTSM can help your oncology trial stay on track. https://bit.ly/3V0T0WL #ClinicalTrials #ClinicalDataManagement #EDC #ePRO #eConsent #RTSM #PatientCentricity

Looking to stay ahead of the competition in the Early Phase #Oncology space? Join our virtual fireside chat and gain valuable regional insights from industry experts. Our webinar, now available on-demand, provides a unique opportunity to learn about Project Optimus and its impact on the industry. Don't miss out on this chance to gain exclusive access to this must-see webinar and stay up-to-date with the latest trends in Early Phase Oncology. Click here to join the conversation: https://bit.ly/3TmHLXa #oncologytrial #clinicaltrials

Did you know that in 2023, Inizio worked on 148 oncology assets? With 91 of these being small molecule oncology assets. By leveraging technology and the latest medical and scientific data, along with HCP and patient insights, Inizio helps to support actionable outcomes for you. Want to learn more about our oncology expertise? Visit booth 37157 at the ASCO® Annual Meeting in Chicago this weekend. https://lnkd.in/ggTHcREU #ASCO24 #oncology

We’re Live! Our President & CEO, Mazhar Jaffry, is at the Oncology Site Solutions Summit! Don't miss the chance to see him in action during a panel discussion on "Tech-Driven Strategies for Site Excellence." Don’t miss out on this engaging session and explore how technologies are transforming clinical trials and how research sites can leverage them to achieve optimal performance. Gain valuable insights and hear Mazhar Jaffry share his expertise! #SCRS #Oncology #OncologyResearch #OncologySiteSolutionsSummit #TechnologyInClinicalTrials #ClinicalTrials #RevivalResearchInstitute

Will you be joining us tomorrow? Learn how AI technologies can accelerate oncology drug discovery and enhance the success of anti-cancer agents, with Certis Oncology Solutions, Inc. Last day to save your spot - Register here: https://lnkd.in/gkB73N5Y #oncology #AI #drugdevelopment

Achieving Launch Excellence in #oncology is increasingly challenging as healthcare systems struggle to keep up with the pace of oncology innovation. Discover key strategies to overcome challenges for a successful oncology #launch. Learn more: https://bit.ly/3STIP4s